Saito et al. reported a novel mechanism by which LLGL2 interacts with its cargo, SLC7A5, in the cytoplasm and transports it to the membrane, increasing SLC7A5 levels on the cell surface in Erα-positive breast cancer. Here, SLC7A5 is linked to breast carcinoma.